- IQVIA Holdings Inc IQV has posted Q3 adjusted EPS of $2.17, up 33% Y/Y, marginally surpassing the consensus of $2.12
- Revenue of $3.4 billion increased 21.7% on a reported basis and 21.1 percent at constant currency, ahead of the consensus of $3.35 billion.
- Technology & Analytics Solutions' revenue of $1.3 billion grew 10.8% on a reported basis and 9.9% at constant currency.
- Research & Development Solutions (R&DS) revenue increased 32.4% on a reported basis and 31.9% at constant currency to $1.8 billion. R&D Solutions contracted backlog of $24.4 billion grew 12.7% Y/Y.
- Adjusted EBITDA increased 20.5% to $728 million.
- Q3 Operating cash flow was $844 million, and free cash flow was $682 million.
- Outlook: IQVIA has raised FY21 sales guidance to $13.77 billion - $13.85 billion, versus ($13.55 billion - $13.70 billion expected earlier), vs. street estimate of $13.68 billion.
- It forecasts adjusted EPS of $8.85 - $8.95, compared to earlier guidance of $8.70 - $8.90, compared to the $8.83 consensus.
- Adjusted EBITDA is expected to be $2.9 billion - $3 billion.
- Price Action: IQV shares traded lower by 4.58% at $240 premarket on the last check Thursday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in